387 related articles for article (PubMed ID: 20460892)
1. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
2. Aetiopathogenesis of autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
[TBL] [Abstract][Full Text] [Related]
3. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
4. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
[TBL] [Abstract][Full Text] [Related]
8. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
9. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
[TBL] [Abstract][Full Text] [Related]
10. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C in the advanced adult and elderly subjects.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
[TBL] [Abstract][Full Text] [Related]
12. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
[TBL] [Abstract][Full Text] [Related]
13. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
Longhi MS; Ma Y; Mitry RR; Bogdanos DP; Heneghan M; Cheeseman P; Mieli-Vergani G; Vergani D
J Autoimmun; 2005 Aug; 25(1):63-71. PubMed ID: 16005184
[TBL] [Abstract][Full Text] [Related]
14. The impact of autoimmunity on hepatocytes.
Vergani D; Mieli-Vergani G
Semin Liver Dis; 2007 May; 27(2):140-51. PubMed ID: 17520514
[TBL] [Abstract][Full Text] [Related]
15. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
16. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.
Ichiki Y; He XS; Shimoda S; Ishibashi H; Keeffe EB; Rossaro L; Gershwin ME
Autoimmun Rev; 2005 Feb; 4(2):82-95. PubMed ID: 15722254
[TBL] [Abstract][Full Text] [Related]
17. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
Longhi MS; Ma Y; Bogdanos DP; Cheeseman P; Mieli-Vergani G; Vergani D
J Hepatol; 2004 Jul; 41(1):31-7. PubMed ID: 15246204
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children.
Cherñavsky AC; Paladino N; Rubio AE; De Biasio MB; Periolo N; Cuarterolo M; Goñi J; Galoppo C; Cañero-Velasco MC; Muñoz AE; Fainboim H; Fainboim L
Hum Immunol; 2004 Jul; 65(7):683-91. PubMed ID: 15301856
[TBL] [Abstract][Full Text] [Related]
19. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients.
Saoudi A; Castedo M; Nochy D; Mandet C; Pasquier R; Druet P; Pelletier L
Eur J Immunol; 1995 Jul; 25(7):1972-9. PubMed ID: 7621873
[TBL] [Abstract][Full Text] [Related]
20. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]